Centiva Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-14,505
| Closed | -$5.88M | – | 1943 |
|
|
2025
Q2 | $5.88M | Buy |
14,505
+3,150
| +28% | +$1.32M | 0.39% | 128 |
|
|
2025
Q1 | $5.65M | Buy |
11,355
+5,109
| +82% | +$2.77M | 0.33% | 56 |
|
|
2024
Q4 | $3.25M | Sell |
6,246
-4,293
| -41% | -$2.36M | 0.12% | 158 |
|
|
2024
Q3 | $6.52M | Sell |
10,539
-13,855
| -57% | -$8.2M | 0.3% | 133 |
|
|
2024
Q2 | $13.5M | Buy |
24,394
+22,287
| +1,058% | +$12.8M | 0.65% | 50 |
|
|
2024
Q1 | $1.22M | Buy |
+2,107
| New | +$1.18M | 0.07% | 560 |
|
|
2023
Q4 | – | Sell |
-8,672
| Closed | -$4.2M | – | 2285 |
|
|
2023
Q3 | $4.39M | Sell |
8,672
-9,554
| -52% | -$5.09M | 0.22% | 186 |
|
|
2023
Q2 | $9.51M | Buy |
+18,226
| New | +$9.84M | 0.48% | 77 |
|
|
2023
Q1 | – | Sell |
-1,191
| Closed | -$656K | – | 1883 |
|
|
2022
Q4 | $656K | Buy |
1,191
+973
| +446% | +$516K | 0.05% | 690 |
|
|
2022
Q3 | $111K | Sell |
218
-875
| -80% | -$490K | 0.01% | 1274 |
|
|
2022
Q2 | $594K | Sell |
1,093
-3,165
| -74% | -$1.74M | 0.03% | 846 |
|
|
2022
Q1 | $2.52M | Buy |
4,258
+120
| +3% | +$68.9K | 0.15% | 356 |
|
|
2021
Q4 | $2.76M | Buy |
4,138
+3,650
| +748% | +$2.28M | 0.18% | 290 |
|
|
2021
Q3 | $279K | Sell |
488
-424
| -46% | -$233K | 0.02% | 810 |
|
|
2021
Q2 | $460K | Buy |
+912
| New | +$430K | 0.04% | 868 |
|
|
2020
Q4 | – | Sell |
-2,851
| Closed | -$1.26M | – | 1129 |
|
|
2020
Q3 | $1.26M | Buy |
2,851
+571
| +25% | +$236K | 0.2% | 169 |
|
|
2020
Q2 | $826K | Buy |
2,280
+1,683
| +282% | +$564K | 0.19% | 206 |
|
|
2020
Q1 | $169K | Sell |
597
-1,009
| -63% | -$318K | 0.03% | 455 |
|
|
2019
Q4 | $522K | Buy |
+1,606
| New | +$487K | 0.09% | 416 |
|